
Nancy Davidson
Executive Vice President and Chief Academic Officer, Fred Hutch · University of Washington School of Medicine
Credentials: · · · ·
History
PresentHematology NIH T32 Grant Section Head/ Executive Vice President and Chief Academic Officer · University of Washington School of Medicine


- 1982–1984
- 1975–1979
- 1971–1975
Research
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
New England Journal of Medicine · 2005 · 4,152 citations
Mutations in the p53 gene occur in diverse human tumour types
Nature · 1989 · 2,955 citations
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
New England Journal of Medicine · 2007 · Last of 9 authors · 2,445 citations
- EP
46 papers
- SM
39 papers
- AW
37 papers

31 papers

31 papers

30 papers

27 papers

22 papers
Grants
- 1985–2030
Training in Cancer Biology and Transplantation
National Cancer Institute · T32
Contact PI · $6.7M · University of Washington
- 1997–2027
Career Development in Pediatric and Medical Oncology
National Cancer Institute · K12
PI · $3.3M · Fred Hutchinson Cancer Center
- 1997–2024
National Cancer Institute · P30
Project lead · $224.5K · Fred Hutchinson Cancer Center
- 2010–2024
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
National Cancer Institute · UM1
Contact PI · $7.6M · Fred Hutchinson Cancer Center
Clinical trials
- 2020–2021
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
